Magnetic resonance‐guided laser interstitial laser therapy (MRgLITT) and radiofrequency
ablation (RFA) represent two minimally invasive methods for the treatment of drug‐refractory …

Background: Ablative therapies have been used for the treatment of neurological disorders
for many years. They have been used both for creating therapeutic lesions within …

Objective Laser interstitial thermal therapy (LITT) for mesial temporal lobe epilepsy (mTLE)
has reported seizure freedom rates between 36% and 78% with at least 1 year of follow‐up …

Objectives Laser interstitial thermal therapy (LITT) is a minimally invasive surgical technique
for focal epilepsy. A major appeal of LITT is that it may result in fewer cognitive deficits …

BACKGROUND For patients with focal drug-resistant epilepsy (DRE), surgical resection of
the epileptogenic zone (EZ) may offer seizure freedom and benefits for quality of life. Yet …

Surgery can cure or significantly improve both the frequency and the intensity of seizures in
patients with medication‐refractory epilepsy. The set of diagnostic and therapeutic …

Objectives: One-third of individuals with focal epilepsy do not achieve seizure freedom
despite best medical therapy. Mesial temporal lobe epilepsy (MTLE) is the most common …

Background Laser interstitial thermal therapy (LITT) has emerged as a safe and effective
approach to the treatment of temporal lobe epilepsy (TLE). The relationship of ablation …

Objective To report one-year seizure outcomes, procedural data, and quality of life scores
following laser interstitial thermal therapy (LITT) of epileptogenic foci. Methods Data from an …

Objective Stereotactic laser amygdalohippocampotomy (SLAH) is an appealing option for
patients with temporal lobe epilepsy, who often require intracranial monitoring to confirm …